{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:00:21Z","timestamp":1793948421111,"version":"4.8.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Cycle monitoring via ultrasound and serum-based hormonal assays during medically assisted reproduction (MAR) can provide information on ovarian response and assist in optimizing treatment strategies in addition to reducing complications such as ovarian hyperstimulation syndrome (OHSS). Two surveys conducted in 2019 and 2020, including overall 24 fertility specialists from Europe, Asia and Latin America, confirmed that the majority of fertility practitioners routinely conduct hormone monitoring during MAR. However, blood tests may cause inconvenience to patients. The reported drawbacks of blood tests identified by the survey included the validity of results from different service providers, long waiting times and discomfort to patients due to travelling to clinics for tests and repeated venepunctures. Historically, urine-based assays were used by fertility specialists in clinics but were subsequently replaced by more practical and automated serum-based assays. A remote urine-based hormonal assay could be an alternative to current serum-based testing at clinics, reducing the inconvenience of blood tests and the frequency of appointments, waiting times and patient burden. Here we provide an overview of the current standard of care for cycle monitoring and review the literature to assess the correlation between urine-based hormonal assays and serum-based hormonal assays during MAR. In addition, in this review, we discuss the evidence supporting the introduction of remote urine-based hormonal monitoring as part of a novel digital health solution that includes remote ultrasound and tele-counselling to link clinics and patients at home.<\/jats:p>","DOI":"10.1007\/s43032-021-00754-5","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T16:04:13Z","timestamp":1636992253000},"page":"3147-3160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Self-Monitoring of Urinary Hormones in Combination with Telemedicine \u2014 a Timely Review and Opinion Piece in Medically Assisted Reproduction"],"prefix":"10.1007","volume":"29","author":[{"given":"Roger J.","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u2019Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline A. F.","family":"Dancet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Aurell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lunenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0799-3474","authenticated-orcid":false,"given":"Wenjing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"754_CR1","unstructured":"Lunenfeld B, Donini P. Le traitement de l\u2019anovulation par les hormones gonadotropes humaines. Annales d\u2019 Endocrinologie. 1964(25):156"},{"issue":"1","key":"754_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12522-011-0097-2","volume":"11","author":"B Lunenfeld","year":"2012","unstructured":"Lunenfeld B. Gonadotropin stimulation: past, present and future. Reprod Med Biol. 2012;11(1):11\u201325. https:\/\/doi.org\/10.1007\/s12522-011-0097-2.","journal-title":"Reprod Med Biol"},{"issue":"8","key":"754_CR3","first-page":"Cd005289","volume":"2014","author":"I Kwan","year":"2014","unstructured":"Kwan I, Bhattacharya S, Kang A, Woolner A. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev. 2014;2014(8):Cd005289.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"754_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.rbmo.2015.03.002","volume":"30","author":"P Patrizio","year":"2015","unstructured":"Patrizio P, Vaiarelli A, Levi Setti PE, Tobler KJ, Shoham G, Leong M, et al. How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. Reprod Biomed Online. 2015;30(6):581\u201392. https:\/\/doi.org\/10.1016\/j.rbmo.2015.03.002.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"754_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.rbmo.2020.10.012","volume":"42","author":"D Sakkas","year":"2021","unstructured":"Sakkas D, Howles CM, Atkinson L, Borini A, Bosch EA, Bryce C, et al. A multi-centre international study of salivary hormone oestradiol and progesterone measurements in ART monitoring. Reprod Biomed Online. 2021;42(2):421\u20138. https:\/\/doi.org\/10.1016\/j.rbmo.2020.10.012.","journal-title":"Reprod Biomed Online"},{"key":"754_CR6","doi-asserted-by":"crossref","unstructured":"Yovich J. Monitoring the Stimulated IVF Cycle. In: Kovacs G, Rutherford A, Gardner D, editors. How to Prepare the Egg and Embryo to Maximize IVF Success Cambridge: Cambridge University Press; 2019. p. 94-120.","DOI":"10.1017\/9781316756744.008"},{"issue":"7","key":"754_CR7","first-page":"841","volume":"31","author":"RK Callow","year":"1938","unstructured":"Callow RK. The significance of the excretion of sex hormones in the urine: (section of therapeutics and pharmacology). Proc R Soc Med. 1938;31(7):841\u201356.","journal-title":"Proc R Soc Med"},{"issue":"8","key":"754_CR8","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/humrep\/dew111","volume":"31","author":"K Lankreijer","year":"2016","unstructured":"Lankreijer K, D\u2019Hooghe T, Sermeus W, van Asseldonk FP, Repping S, Dancet EA. Development and validation of the FertiMed questionnaire assessing patients\u2019 experiences with hormonal fertility medication. Hum Reprod (Oxford, England). 2016;31(8):1799\u2013808. https:\/\/doi.org\/10.1093\/humrep\/dew111.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"1","key":"754_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/humrep\/del344","volume":"22","author":"M Redshaw","year":"2007","unstructured":"Redshaw M, Hockley C, Davidson LL. A qualitative study of the experience of treatment for infertility among women who successfully became pregnant. Hum Reprod (Oxford, England). 2007;22(1):295\u2013304. https:\/\/doi.org\/10.1093\/humrep\/del344.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"2","key":"754_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/humrep\/deu307","volume":"30","author":"L van den Wijngaard","year":"2015","unstructured":"van den Wijngaard L, Rodijk IC, van der Veen F, Gooskens-van Erven MH, Koks CA, Verhoeve HR, et al. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment. Hum Reprod (Oxford, England). 2015;30(2):331\u20137. https:\/\/doi.org\/10.1093\/humrep\/deu307.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"5","key":"754_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/humupd\/dmq004","volume":"16","author":"EA Dancet","year":"2010","unstructured":"Dancet EA, Nelen WL, Sermeus W, De Leeuw L, Kremer JA, D\u2019Hooghe TM. The patients\u2019 perspective on fertility care: a systematic review. Hum Reprod Update. 2010;16(5):467\u201387. https:\/\/doi.org\/10.1093\/humupd\/dmq004.","journal-title":"Hum Reprod Update"},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1477-7525-11-130","volume":"11","author":"M Brod","year":"2013","unstructured":"Brod M, Fennema H. Validation of the controlled ovarian stimulation impact measure (COSI): assessing the patient perspective. Health Qual Life Outcomes. 2013;11:130. https:\/\/doi.org\/10.1186\/1477-7525-11-130.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"754_CR13","doi-asserted-by":"publisher","first-page":"hoaa033","DOI":"10.1093\/hropen\/hoaa033","volume":"2020","author":"A Veiga","year":"2020","unstructured":"Veiga A, Gianaroli L, Ory S, Horton M, Feinberg E, Penzias A. Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE and IFFS. Hum Reprod Open. 2020;2020(3):hoaa033. https:\/\/doi.org\/10.1093\/hropen\/hoaa033.","journal-title":"Hum Reprod Open"},{"issue":"3","key":"754_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.rbmo.2020.07.002","volume":"41","author":"ADAC Smith","year":"2020","unstructured":"Smith ADAC, Gromski PS, Rashid KA, Tilling K, Lawlor DA, Nelson SM. Population implications of cessation of IVF during the COVID-19 pandemic. Reprod Biomed Online. 2020;41(3):428\u201330. https:\/\/doi.org\/10.1016\/j.rbmo.2020.07.002.","journal-title":"Reprod Biomed Online"},{"key":"754_CR15","unstructured":"German IVF Register D.I.R. D.I.R special evaluation: effects of the COVID-19 situation on reproductive medicine in Germany, 2020 as a whole.\u00a0Available from https:\/\/www.deutsches-ivf-register.de\/aktuelle-nachrichten-des-dir.php. 2021.\u00a0 Accessed Mar\u00a02021."},{"issue":"3","key":"754_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.rbmo.2020.05.015","volume":"41","author":"DA Vaughan","year":"2020","unstructured":"Vaughan DA, Shah JS, Penzias AS, Domar AD, Toth TL. Infertility remains a top stressor despite the COVID-19 pandemic. Reprod Biomed Online. 2020;41(3):425\u20137. https:\/\/doi.org\/10.1016\/j.rbmo.2020.05.015.","journal-title":"Reprod Biomed Online"},{"key":"754_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2020.08.025","volume":"253","author":"V Esposito","year":"2020","unstructured":"Esposito V, Rania E, Lico D, Pedri S, Fiorenza A, Strati MF, et al. Influence of COVID-19 pandemic on the psychological status of infertile couples. Eur J Obstet Gynecol Reprod Biol. 2020;253:148\u201353. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.08.025.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"754_CR18","unstructured":"World Health Organization: Maintaining essential health services: operational guidance for the COVID-19 context. Interim guidance 1 June 2020. https:\/\/www.who.int\/teams\/sexual-and-reproductive-health-and-research\/key-areas-of-work\/sexual-reproductive-health-and-rights-in-health-emergencies\/covid-19 (2020). Accessed 26 November 2020."},{"key":"754_CR19","unstructured":"World Health Organization: Infertility definitions and terminology. https:\/\/www.who.int\/teams\/sexual-and-reproductive-health-and-research\/key-areas-of-work\/fertility-care\/infertility-definitions-and-terminology (2021). Accessed February 2021."},{"issue":"2","key":"754_CR20","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"E Bosch","year":"2020","unstructured":"The ESHRE Guideline Group on Ovarian Stimulation, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. https:\/\/doi.org\/10.1093\/hropen\/hoaa009.","journal-title":"Hum Reprod Open"},{"issue":"6","key":"754_CR21","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.fertnstert.2015.03.019","volume":"103","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2015","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015;103(6):e44-50. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.03.019.","journal-title":"Fertil Steril"},{"issue":"6","key":"754_CR22","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1097\/AOG.0000000000003271","volume":"133","author":"Committee on Gynecologic Practice - American Society for Reproductive Medicine","year":"2019","unstructured":"Committee on Gynecologic Practice - American Society for Reproductive Medicine. Infertility Workup for the Women\u2019s Health Specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol. 2019;133(6):e377\u201384.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"754_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.fertnstert.2018.04.037","volume":"109","author":"BW Mol","year":"2018","unstructured":"Mol BW, Bossuyt PM, Sunkara SK, Garcia Velasco JA, Venetis C, Sakkas D, et al. Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients. Fertil Steril. 2018;109(6):968\u201379. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.04.037.","journal-title":"Fertil Steril"},{"key":"754_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fendo.2019.00429","volume":"10","author":"B Lunenfeld","year":"2019","unstructured":"Lunenfeld B, Bilger W, Longobardi S, Alam V, D\u2019Hooghe T, Sunkara SK. The development of gonadotropins for clinical use in the treatment of infertility. Front Endocrinol. 2019;10:429. https:\/\/doi.org\/10.3389\/fendo.2019.00429.","journal-title":"Front Endocrinol"},{"key":"754_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","volume":"8","author":"R Orvieto","year":"2015","unstructured":"Orvieto R. Triggering final follicular maturation\u2014hCG, GnRH-agonist or both, when and to whom? Journal of ovarian research. 2015;8:60. https:\/\/doi.org\/10.1186\/s13048-015-0187-6.","journal-title":"Journal of ovarian research"},{"key":"754_CR26","doi-asserted-by":"crossref","unstructured":"Mahony M, Hayward B, Richter K, D\u2019Hooghe T. Abstracts of the 34th Annual Meeting of the ESHRE, Barcelona, Spain, 1\u20134 July 2018. Occurrence and characteristics of recombinant human follicle-stimulating hormone (r-hFSH) dose adjustments during ovarian stimulation in a real-world US database study of 33,962 IVF patient cycles, P659. Hum Reprod (Oxford, England). 2018;33(suppl_1):i444.","DOI":"10.26226\/morressier.5af300b2738ab10027aa998b"},{"issue":"1","key":"754_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12958-021-00744-x","volume":"19","author":"H Fatemi","year":"2021","unstructured":"Fatemi H, Bilger W, Denis D, Griesinger G, La Marca A, Longobardi S, et al. Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007\u20132017). Reprod Biol Endocrinol. 2021;19(1):68. https:\/\/doi.org\/10.1186\/s12958-021-00744-x.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"754_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/humrep\/dey061","volume":"33","author":"A La Marca","year":"2018","unstructured":"La Marca A, Blockeel C, Bosch E, Fanchin R, Fatemi HM, Fauser BC, et al. Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates. Hum Reprod. 2018;33(5):982\u20133. https:\/\/doi.org\/10.1093\/humrep\/dey061.","journal-title":"Hum Reprod"},{"issue":"12","key":"754_CR29","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/humrep\/dex318","volume":"32","author":"TC van Tilborg","year":"2017","unstructured":"van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, et al. Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 1: the predicted poor responder. Hum Reprod (Oxford, England). 2017;32(12):2496\u2013505. https:\/\/doi.org\/10.1093\/humrep\/dex318.","journal-title":"Hum Reprod (Oxford, England)"},{"key":"754_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7827-10-9","volume":"10","author":"C Alviggi","year":"2012","unstructured":"Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol: RB&E. 2012;10:9. https:\/\/doi.org\/10.1186\/1477-7827-10-9.","journal-title":"Reprod Biol Endocrinol: RB&E"},{"key":"754_CR31","unstructured":"Vermeulen N, Le Clef N, D\u2019Angelo A, Veleva Z, Tilleman K: Manual for development of good practice recommendations. https:\/\/www.eshre.eu\/Guidelines-and-Legal\/Guidelines\/Guideline-development-process (2019). Accessed September 2020."},{"issue":"7","key":"754_CR32","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","volume":"106","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2016","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106(7):1634\u201347. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.048.","journal-title":"Fertil Steril"},{"issue":"1","key":"754_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.rbmo.2017.03.024","volume":"35","author":"C Farquhar","year":"2017","unstructured":"Farquhar C, Marjoribanks J, Brown J, Fauser B, Lethaby A, Mourad S, et al. Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance. Reprod Biomed Online. 2017;35(1):3\u201316. https:\/\/doi.org\/10.1016\/j.rbmo.2017.03.024.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"754_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.fertnstert.2019.09.020","volume":"113","author":"Practice Committees of the American Society for Reproductive Medicine and Society for Reproductive Endocrinology and Infertility","year":"2020","unstructured":"Practice Committees of the American Society for Reproductive Medicine and Society for Reproductive Endocrinology and Infertility. Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion. Fertil Steril. 2020;113(1):66\u201370.","journal-title":"Fertil Steril"},{"issue":"2","key":"754_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.fertnstert.2013.05.033","volume":"100","author":"The Practice Committee of the American Society for Reproductive Medicine","year":"2013","unstructured":"The Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100(2):341\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.05.033.","journal-title":"Fertil Steril"},{"issue":"4","key":"754_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13224-018-1130-8","volume":"68","author":"SR Lindheim","year":"2018","unstructured":"Lindheim SR, Glenn TL, Smith MC, Gagneux P. Ovulation induction for the general gynecologist. J Obstet Gynaecol India. 2018;68(4):242\u201352. https:\/\/doi.org\/10.1007\/s13224-018-1130-8.","journal-title":"J Obstet Gynaecol India"},{"key":"754_CR37","unstructured":"International Federation of Fertility Societies: Standard 19: Clomiphene and its use in ovulation induction - Guidance for practitioners. https:\/\/cdn.ymaws.com\/www.iffsreproduction.org\/resource\/resmgr\/practice_standards\/iffs_cc_document_oct17.pdf (2017). Accessed September 2020."},{"issue":"10","key":"754_CR38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s10815-018-1264-8","volume":"35","author":"A Kaponis","year":"2018","unstructured":"Kaponis A, Chronopoulou E, Decavalas G. The curious case of premature luteinization. J Assist Reprod Genet. 2018;35(10):1723\u201340. https:\/\/doi.org\/10.1007\/s10815-018-1264-8.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"754_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.rbmo.2020.10.009","volume":"42","author":"M Wang","year":"2021","unstructured":"Wang M, Xi Q, Yang Q, Li Z, Yang L, Zhu L, et al. The relationship between a novel evaluation parameter of premature luteinization and IVF outcomes. Reprod Biomed Online. 2021;42(2):323\u201331. https:\/\/doi.org\/10.1016\/j.rbmo.2020.10.009.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"754_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12978-017-0375-5","volume":"14","author":"EA Duthie","year":"2017","unstructured":"Duthie EA, Cooper A, Davis JB, Schoyer KD, Sandlow J, Strawn EY, et al. A conceptual framework for patient-centered fertility treatment. Reprod Health. 2017;14(1):114. https:\/\/doi.org\/10.1186\/s12978-017-0375-5.","journal-title":"Reprod Health"},{"issue":"4","key":"754_CR41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.fertnstert.2019.12.040","volume":"113","author":"LM Shandley","year":"2020","unstructured":"Shandley LM, Hipp HS, Anderson-Bialis J, Anderson-Bialis D, Boulet SL, McKenzie LJ, et al. Patient-centered care: factors associated with reporting a positive experience at United States fertility clinics. Fertil Steril. 2020;113(4):797\u2013810. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.12.040.","journal-title":"Fertil Steril"},{"issue":"4","key":"754_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/humrep\/der022","volume":"26","author":"EA Dancet","year":"2011","unstructured":"Dancet EA, Van Empel IW, Rober P, Nelen WL, Kremer JA, D\u2019Hooghe TM. Patient-centred infertility care: a qualitative study to listen to the patient\u2019s voice. Hum Reprod (Oxford, England). 2011;26(4):827\u201333. https:\/\/doi.org\/10.1093\/humrep\/der022.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"8","key":"754_CR43","doi-asserted-by":"publisher","first-page":"e0135652","DOI":"10.1371\/journal.pone.0135652","volume":"10","author":"LWM van Kerkhof","year":"2015","unstructured":"van Kerkhof LWM, Van Dycke KCG, Jansen EHJM, Beekhof PK, van Oostrom CTM, Ruskovska T, et al. Diurnal variation of hormonal and lipid biomarkers in a molecular epidemiology-like setting. PLoS ONE. 2015;10(8):e0135652-e. https:\/\/doi.org\/10.1371\/journal.pone.0135652.","journal-title":"PLoS ONE"},{"issue":"3","key":"754_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0015-0282(16)61356-0","volume":"8","author":"R Borth","year":"1957","unstructured":"Borth R, Lunenfeld B, De Watteville H. Day-to-day variation in urinary gonadotrophin and steroid levels during the normal menstrual cycle. Fertil Steril. 1957;8(3):233\u201354. https:\/\/doi.org\/10.1016\/s0015-0282(16)61356-0.","journal-title":"Fertil Steril"},{"issue":"6","key":"754_CR45","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3109\/13625187.2015.1048331","volume":"20","author":"J Roos","year":"2015","unstructured":"Roos J, Johnson S, Weddell S, Godehardt E, Schiffner J, Freundl G, et al. Monitoring the menstrual cycle: comparison of urinary and serum reproductive hormones referenced to true ovulation. Eur J Contracept Reprod Health Care. 2015;20(6):438\u201350. https:\/\/doi.org\/10.3109\/13625187.2015.1048331.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"754_CR46","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1172\/jci111370","volume":"73","author":"M Filicori","year":"1984","unstructured":"Filicori M, Butler JP, Crowley WF Jr. Neuroendocrine regulation of the corpus luteum in the human Evidence for pulsatile progesterone secretion. J Clin Investi. 1984;73(6):1638\u201347. https:\/\/doi.org\/10.1172\/jci111370.","journal-title":"J Clin Investi"},{"issue":"2","key":"754_CR47","first-page":"63","volume":"23","author":"S Rapi","year":"1992","unstructured":"Rapi S, Fuzzi B, Mannelli M, Pratesi S, Criscuoli L, Pellegrini S, et al. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity. Acta Eur Fertil. 1992;23(2):63\u20138.","journal-title":"Acta Eur Fertil"},{"issue":"1","key":"754_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13065-019-0539-1","volume":"13","author":"M Newman","year":"2019","unstructured":"Newman M, Pratt SM, Curran DA, Stanczyk FZ. Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC-MS\/MS). BMC Chem. 2019;13(1):20. https:\/\/doi.org\/10.1186\/s13065-019-0539-1.","journal-title":"BMC Chem"},{"key":"754_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fpubh.2018.00153","volume":"6","author":"LF Blackwell","year":"2018","unstructured":"Blackwell LF, Cooke DG, Brown S. The use of estrone-3-glucuronide and pregnanediol-3-glucuronide excretion rates to navigate the continuum of ovarian activity. Front Public Health. 2018;6:153. https:\/\/doi.org\/10.3389\/fpubh.2018.00153.","journal-title":"Front Public Health"},{"issue":"5","key":"754_CR50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/s0015-0282(16)47060-3","volume":"39","author":"World Health Organization","year":"1983","unstructured":"World Health Organization. Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction. Temporal relationships between indices of the fertile period. Fertil Steril. 1983;39(5):647\u201355. https:\/\/doi.org\/10.1016\/s0015-0282(16)47060-3.","journal-title":"Fertil Steril"},{"issue":"3","key":"754_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0039-128x(78)90053-3","volume":"31","author":"K Wright","year":"1978","unstructured":"Wright K, Collins DC, Musey PI, Preedy JR. Direct radioimmunoassay of specific urinary estrogen glucosiduronates in normal men and nonpregnant women. Steroids. 1978;31(3):407\u201326. https:\/\/doi.org\/10.1016\/0039-128x(78)90053-3.","journal-title":"Steroids"},{"issue":"4","key":"754_CR52","first-page":"271","volume":"34","author":"R Catalan","year":"1989","unstructured":"Catalan R, Castellanos JM, Palomino T, Senti M, Antolin M, Galard RM. Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy. Int J Fertil. 1989;34(4):271\u20135.","journal-title":"Int J Fertil"},{"issue":"1","key":"754_CR53","first-page":"5","volume":"58","author":"JH Denari","year":"1981","unstructured":"Denari JH, Farinati Z, Casas PR, Oliva A. Determination of ovarian function using first morning urine steroid assays. Obstet Gynecol. 1981;58(1):5\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"754_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0028-2243(85)90080-2","volume":"20","author":"Y Frenkel","year":"1985","unstructured":"Frenkel Y, Eshkol A, Tikotzky D, Mashiach S, Lunenfeld B. Excretion of total estrogens and estrone-3-glucuronide during treatment with human menopausal gonadotropins. Eur J Obstet Gynecol Reprod Biol. 1985;20(1):27\u201333. https:\/\/doi.org\/10.1016\/0028-2243(85)90080-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"754_CR55","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1042\/bj1770729","volume":"177","author":"TS Baker","year":"1979","unstructured":"Baker TS, Jennison KM, Kellie AE. The direct radioimmunoassay of oestrogen glucuronides in human female urine. Biochem J. 1979;177(2):729\u201338. https:\/\/doi.org\/10.1042\/bj1770729.","journal-title":"Biochem J"},{"issue":"2","key":"754_CR56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0022-4731(82)90189-3","volume":"16","author":"CM Branch","year":"1982","unstructured":"Branch CM, Collins PO, Collins WP. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles. J Steroid Biochem. 1982;16(2):345\u20137. https:\/\/doi.org\/10.1016\/0022-4731(82)90189-3.","journal-title":"J Steroid Biochem"},{"issue":"4","key":"754_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0002-9378(80)91125-4","volume":"137","author":"FZ Stanczyk","year":"1980","unstructured":"Stanczyk FZ, Miyakawa I, Goebelsmann U. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle. Am J Obstet Gynecol. 1980;137(4):443\u201350. https:\/\/doi.org\/10.1016\/0002-9378(80)91125-4.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"754_CR58","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/s0015-0282(16)59416-3","volume":"48","author":"JB Lessing","year":"1987","unstructured":"Lessing JB, Peyser MR, Gilad S, Amit A, Kogosowski A, Yovel I, et al. Estrone-3-glucuronide chemiluminescence immunoassay: an alternative method for monitoring induction of ovulation with human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril. 1987;48(3):450\u20133. https:\/\/doi.org\/10.1016\/s0015-0282(16)59416-3.","journal-title":"Fertil Steril"},{"issue":"1","key":"754_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0022-4731(74)90022-3","volume":"5","author":"R Hobkirk","year":"1974","unstructured":"Hobkirk R, Nilsen M. Early urinary conjugated metabolites of intravenously injected (6,7\u20133H)-estradiol-17beta in the human subject. J Steroid Biochem. 1974;5(1):15\u201320. https:\/\/doi.org\/10.1016\/0022-4731(74)90022-3.","journal-title":"J Steroid Biochem"},{"issue":"8","key":"754_CR60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF02211727","volume":"11","author":"MM Alper","year":"1994","unstructured":"Alper MM, Halvorson L, Lasley B, Mortola J. Relationship between urinary estrone conjugates as measured by enzyme immunoassay and serum estradiol in women receiving gonadotropins for in vitro fertilization. J Assist Reprod Genet. 1994;11(8):405\u20138. https:\/\/doi.org\/10.1007\/BF02211727.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"754_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0039-128x(94)90029-9","volume":"59","author":"JS Kesner","year":"1994","unstructured":"Kesner JS, Knecht EA, Krieg EF Jr, Barnard G, Mikola HJ, Kohen F, et al. Validations of time-resolved fluoroimmunoassays for urinary estrone 3-glucuronide and pregnanediol 3-glucuronide. Steroids. 1994;59(3):205\u201311. https:\/\/doi.org\/10.1016\/0039-128x(94)90029-9.","journal-title":"Steroids"},{"issue":"6","key":"754_CR62","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/clinchem\/37.6.838","volume":"37","author":"CJ Munro","year":"1991","unstructured":"Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet JW, Lasley BL. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem. 1991;37(6):838\u201344.","journal-title":"Clin Chem"},{"issue":"7","key":"754_CR63","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1373\/49.7.1139","volume":"49","author":"KA O'Connor","year":"2003","unstructured":"O\u2019Connor KA, Brindle E, Holman DJ, Klein NA, Soules MR, Campbell KL, et al. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem. 2003;49(7):1139\u201348. https:\/\/doi.org\/10.1373\/49.7.1139.","journal-title":"Clin Chem"},{"issue":"1-3","key":"754_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0022-4731(87)90333-5","volume":"27","author":"M Pazzagli","year":"1987","unstructured":"Pazzagli M, Magini A, Forti G, Bolelli G, Scarselli G, Noci I, et al. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency. J Steroid Biochem. 1987;27(1\u20133):399\u2013404. https:\/\/doi.org\/10.1016\/0022-4731(87)90333-5.","journal-title":"J Steroid Biochem"},{"issue":"6","key":"754_CR65","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0015-0282(16)54008-4","volume":"54","author":"SJ Thornton","year":"1990","unstructured":"Thornton SJ, Pepperell RJ, Brown JB. Home monitoring of gonadotropin ovulation induction using the ovarian monitor. Fertil Steril. 1990;54(6):1076\u201382.","journal-title":"Fertil Steril"},{"issue":"5","key":"754_CR66","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1373\/clinchem.2004.032292","volume":"50","author":"RC Miller","year":"2004","unstructured":"Miller RC, Brindle E, Holman DJ, Shofer J, Klein NA, Soules MR, et al. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin Chem. 2004;50(5):924\u201332. https:\/\/doi.org\/10.1373\/clinchem.2004.032292.","journal-title":"Clin Chem"},{"issue":"2","key":"754_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/bf00378371","volume":"55","author":"L Alessio","year":"1985","unstructured":"Alessio L, Berlin A, Dell\u2019Orto A, Toffoletto F, Ghezzi I. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health. 1985;55(2):99\u2013106. https:\/\/doi.org\/10.1007\/bf00378371.","journal-title":"Int Arch Occup Environ Health"},{"key":"754_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.apradiso.2018.02.007","volume":"136","author":"PD Sawant","year":"2018","unstructured":"Sawant PD, Kumar SA, Wankhede S, Rao DD. Creatinine as a normalization factor to estimate the representativeness of urine sample \u2014 intra-subject and inter-subject variability studies. Appl Radiat Isot. 2018;136:121\u20136. https:\/\/doi.org\/10.1016\/j.apradiso.2018.02.007.","journal-title":"Appl Radiat Isot."},{"issue":"1","key":"754_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.contraception.2005.07.008","volume":"73","author":"LJ Severy","year":"2006","unstructured":"Severy LJ, Robinson J, Findley-Klein C, McNulty J. Acceptability of a home monitor used to aid in conception: psychosocial factors and couple dynamics. Contraception. 2006;73(1):65\u201371. https:\/\/doi.org\/10.1016\/j.contraception.2005.07.008.","journal-title":"Contraception"},{"issue":"3","key":"754_CR70","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clinbiochem.2016.09.016","volume":"50","author":"T Fiers","year":"2017","unstructured":"Fiers T, Dielen C, Somers S, Kaufman J-M, Gerris J. Salivary estradiol as a surrogate marker for serum estradiol in assisted reproduction treatment. Clin Biochem. 2017;50(3):145\u20139. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.09.016.","journal-title":"Clin Biochem"},{"issue":"Pt 6","key":"754_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/000456328101800604","volume":"18","author":"AR MacLean","year":"1981","unstructured":"MacLean AR, Outch KH, Russell JM, Brown JB, Dennis PM. Monitoring induction of ovulation by rapid radioimmunoassays of oestrogen and pregnanediol glucuronides. Ann Clin Biochem. 1981;18(Pt 6):343\u20139. https:\/\/doi.org\/10.1177\/000456328101800604.","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"754_CR72","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1089\/tmj.2011.0103","volume":"17","author":"R Bashshur","year":"2011","unstructured":"Bashshur R, Shannon G, Krupinski E, Grigsby J. The taxonomy of telemedicine. Telemed J E Health. 2011;17(6):484\u201394. https:\/\/doi.org\/10.1089\/tmj.2011.0103.","journal-title":"Telemed J E Health."},{"issue":"1","key":"754_CR73","first-page":"35","volume":"103","author":"VA Diaz","year":"2020","unstructured":"Diaz VA, Player MS. Direct-to-Patient Telehealth: opportunities and challenges. R I Med J (2013). 2020;103(1):35\u20137.","journal-title":"R I Med J (2013)"},{"issue":"11","key":"754_CR74","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ijmedinf.2010.08.006","volume":"79","author":"AG Ekeland","year":"2010","unstructured":"Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Informatics. 2010;79(11):736\u201371. https:\/\/doi.org\/10.1016\/j.ijmedinf.2010.08.006.","journal-title":"Int J Med Informatics"},{"issue":"1","key":"754_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.dhjo.2015.08.008","volume":"9","author":"AP Turner","year":"2016","unstructured":"Turner AP, Roubinov DS, Atkins DC, Haselkorn JK. Predicting medication adherence in multiple sclerosis using telephone-based home monitoring. Disabil Health J. 2016;9(1):83\u20139. https:\/\/doi.org\/10.1016\/j.dhjo.2015.08.008.","journal-title":"Disabil Health J"},{"issue":"10","key":"754_CR76","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1177\/1352458519857075","volume":"25","author":"G Brichetto","year":"2019","unstructured":"Brichetto G, Pedulla L, Podda J, Tacchino A. Beyond center-based testing: understanding and improving functioning with wearable technology in MS. Mult Scler. 2019;25(10):1402\u201311. https:\/\/doi.org\/10.1177\/1352458519857075.","journal-title":"Mult Scler"},{"issue":"4","key":"754_CR77","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3233\/jnd-180338","volume":"5","author":"GM Buyse","year":"2018","unstructured":"Buyse GM, Rummey C, Meier T, Leinonen M, Voit T, McDonald CM, et al. Home-based monitoring of pulmonary function in patients with duchenne muscular dystrophy. J Neuromuscul Dis. 2018;5(4):419\u201330. https:\/\/doi.org\/10.3233\/jnd-180338.","journal-title":"J Neuromuscul Dis"},{"issue":"S2","key":"754_CR78","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1089\/dia.2017.0024","volume":"19","author":"AL Carlson","year":"2017","unstructured":"Carlson AL, Mullen DM, Bergenstal RM. Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther. 2017;19(S2):S4-s11. https:\/\/doi.org\/10.1089\/dia.2017.0024.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"754_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11906-019-0916-0","volume":"21","author":"N Liyanage-Don","year":"2019","unstructured":"Liyanage-Don N, Fung D, Phillips E, Kronish IM. Implementing home blood pressure monitoring into clinical practice. Curr Hypertens Rep. 2019;21(2):14. https:\/\/doi.org\/10.1007\/s11906-019-0916-0.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"754_CR80","first-page":"161","volume":"1","author":"J Gerris","year":"2009","unstructured":"Gerris J, Geril A, De Sutter P. Patient acceptance of Self-Operated Endovaginal Telemonitoring (SOET): proof of concept. Facts Views Vis ObGyn. 2009;1(3):161\u201370.","journal-title":"Facts Views Vis ObGyn"},{"issue":"3","key":"754_CR81","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/humrep\/dep440","volume":"25","author":"J Gerris","year":"2010","unstructured":"Gerris J, De Sutter P. Self-operated endovaginal telemonitoring (SOET): a step towards more patient-centred ART? Hum Reprod (Oxford, England). 2010;25(3):562\u20138. https:\/\/doi.org\/10.1093\/humrep\/dep440.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"3","key":"754_CR82","first-page":"141","volume":"8","author":"J Gerris","year":"2016","unstructured":"Gerris J, Vandekerckhove F, De Sutter P. Outcome of one hundred consecutive ICSI attempts using patient operated home sonography for monitoring follicular growth. Facts Views Vis ObGyn. 2016;8(3):141\u20136.","journal-title":"Facts Views Vis ObGyn"},{"issue":"9","key":"754_CR83","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/humrep\/deu168","volume":"29","author":"J Gerris","year":"2014","unstructured":"Gerris J, Delvigne A, Dhont N, Vandekerckhove F, Madoc B, Buyle M, et al. Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCT. Hum Reprod (Oxford, England). 2014;29(9):1941\u20138. https:\/\/doi.org\/10.1093\/humrep\/deu168.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"2","key":"754_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.fertnstert.2016.03.043","volume":"106","author":"I Pereira","year":"2016","unstructured":"Pereira I, von Horn K, Depenbusch M, Schultze-Mosgau A, Griesinger G. Self-operated endovaginal telemonitoring: a prospective, clinical validation study. Fertil Steril. 2016;106(2):306-10.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.03.043.","journal-title":"Fertil Steril"},{"key":"754_CR85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/9781108859486.005","volume-title":"Patient-Centered Assisted Reproduction: How to Integrate Exceptional Care with Cutting-Edge Technology","author":"J Gerris","year":"2020","unstructured":"Gerris J. ART Monitoring: an end to frequent clinic visits and needle sticks? In: Domar AD, Sakkas D, Toth TL, editors. Patient-Centered Assisted Reproduction: How to Integrate Exceptional Care with Cutting-Edge Technology. Cambridge: Cambridge University Press; 2020. p. 39\u201353."},{"issue":"4","key":"754_CR86","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/humrep\/deaa040","volume":"35","author":"TR Zaat","year":"2020","unstructured":"Zaat TR, de Bruin JP, Goddijn M, Visser J, Kaaijk EM, Lambalk CB, et al. Home- or hospital-based monitoring to time frozen embryo transfer in the natural cycle? Patient-reported outcomes and experiences from the Antarctica-2 randomised controlled trial. Hum Reprod (Oxford, England). 2020;35(4):866\u201375. https:\/\/doi.org\/10.1093\/humrep\/deaa040.","journal-title":"Hum Reprod (Oxford, England)"},{"key":"754_CR87","doi-asserted-by":"publisher","unstructured":"Zaat T, de Bruin JP, Goddijn M, Visser J, Verhoeve H, Lambalk CB, et al. Home- or hospital -based monitoring to time frozen embryo transfer in the natural cycle? outcomes from a randomized controlled trial (antarctica-2). Fertil Steril 112(3):e65. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.07.293","DOI":"10.1016\/j.fertnstert.2019.07.293"},{"issue":"12","key":"754_CR88","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/humrep\/15.12.2478","volume":"15","author":"HM Behre","year":"2000","unstructured":"Behre HM, Kuhlage J, Gassner C, Sonntag B, Schem C, Schneider HP, et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod (Oxford, England). 2000;15(12):2478\u201382. https:\/\/doi.org\/10.1093\/humrep\/15.12.2478.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"1","key":"754_CR89","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jhqr.2019.08.004","volume":"35","author":"C Hern\u00e1ndez","year":"2020","unstructured":"Hern\u00e1ndez C, Valdera CJ, Cordero J, L\u00f3pez E, Plaza J, Albi M. Impact of telemedicine on assisted reproduction treatment in the public health system. J Healthc Qual Res. 2020;35(1):27\u201334. https:\/\/doi.org\/10.1016\/j.jhqr.2019.08.004.","journal-title":"J Healthc Qual Res"},{"issue":"2\u20133","key":"754_CR90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10815-010-9387-6","volume":"27","author":"CO Nastri","year":"2010","unstructured":"Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27(2\u20133):121\u20138. https:\/\/doi.org\/10.1007\/s10815-010-9387-6.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"754_CR91","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.fertnstert.2015.06.011","volume":"104","author":"L Meyer","year":"2015","unstructured":"Meyer L, Murphy LA, Gumer A, Reichman DE, Rosenwaks Z, Cholst IN. Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles. Fertil Steril. 2015;104(3):637\u201342. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.06.011.","journal-title":"Fertil Steril"},{"issue":"1","key":"754_CR92","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12905-017-0422-y","volume":"17","author":"T Shochet","year":"2017","unstructured":"Shochet T, Comstock IA, Ngoc NTN, Westphal LM, Sheldon WR, Loc LT, et al. Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends after assisted reproduction. BMC Womens Health. 2017;17(1):67. https:\/\/doi.org\/10.1186\/s12905-017-0422-y.","journal-title":"BMC Womens Health"},{"issue":"1","key":"754_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ogc.2014.10.003","volume":"42","author":"TB Mesen","year":"2015","unstructured":"Mesen TB, Young SL. Progesterone and the luteal phase: a requisite to reproduction. Obstet Gynecol Clin North Am. 2015;42(1):135\u201351. https:\/\/doi.org\/10.1016\/j.ogc.2014.10.003.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"754_CR94","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/bio.1170040174","volume":"4","author":"A Magini","year":"1989","unstructured":"Magini A, Pinzani P, Bolelli GF, Bassi F, Salerno R, Messeri G, et al. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function. J Biolumin Chemilumin. 1989;4(1):567\u201374. https:\/\/doi.org\/10.1002\/bio.1170040174.","journal-title":"J Biolumin Chemilumin"},{"key":"754_CR95","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fpubh.2018.00147","volume":"6","author":"ME Alliende","year":"2018","unstructured":"Alliende ME, Arraztoa JA, Guajardo U, Mellado F. Towards the clinical evaluation of the luteal phase in fertile women: a preliminary study of normative urinary hormone profiles. Front Public Health. 2018;6:147. https:\/\/doi.org\/10.3389\/fpubh.2018.00147.","journal-title":"Front Public Health"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-021-00754-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-021-00754-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-021-00754-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T22:23:37Z","timestamp":1668032617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-021-00754-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":95,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1007\/s43032-021-00754-5","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"1 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"TDH and WZ are employees of the healthcare business of\u00a0Merck KGaA, Darmstadt, Germany. RO received research grants and honoraria for lectures from: the healthcare business of\u00a0Merck KGaA, Darmstadt, Germany, Ferring Pharmaceuticals. NPP has received research grants and honoraria for lectures from: the healthcare business of\u00a0Merck KGaA, Darmstadt, Germany, MSD, Ferring Pharmaceuticals, Besins International, Roche Diagnostics, IBSA, Theramex and Gedeon Richter. RJH is the Medical Director of Fertility Specialists of Western Australia and a shareholder in Western IVF. He has received educational sponsorship from MSD, the healthcare business of\u00a0Merck KGaA, Darmstadt, Germany and Ferring Pharmaceuticals. EADF has received research grants and honoraria for sitting in advisory boards from the healthcare business of\u00a0Merck KGaA, Darmstadt, Germany. BL received honoraria for consultations from the healthcare business of\u00a0Merck KGaA, Darmstadt, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}